postpandemicspac

  • Home
  • Author: postpandemicspac
  • Page 2

Hold Jaguar Health Stock for SPAC Spin-Off and Covid-19 Connection

There’s a lot going on at Jaguar Health, but the net effect should be bullish for JAGX stock By David Moadel, InvestorPlace Contributor The plant-based prescription medicine developer Jaguar Health (NASDAQ:JAGX) is one of the more unique biopharmaceutical companies on the market today. So JAGX stock isn’t for folks who value safety above all else, because Jaguar health […]
Read More

Swiss Growth Forum and TAG Investment Bankers team up to promote the Post Pandemic Recovery SPAC target companies

Swiss Growth Forum is pleased to announce that it is looking to work in close co-operation with TAG Investment Bankers as part of both organizations’ determination to seek investment opportunities for the Post Pandemic Recovery SPAC.  The co-operation will cover fundraising, target identification and the publication of substantive sponsored investment research. Swiss Growth Forum and […]
Read More

UK Covid-19 Variant Sparks Renewed Interest in PPR SPAC

This weekend’s CNBC news item, which highlights the spread of the recently identified UK variant in North America, arguably has important implications for the global scale of the pandemic. In particular, Western Europe’s sizable 540 million population could experience a sizable number of Covid19 “long-haulers.” Hence, the Post Pandemic Recovery SPAC with its targeted direct […]
Read More

Post Pandemic Recovery SPAC target Napo EU and “JAGX” profiled by RealMoney.theStreet.com

JAGX has a drug that is impactful against a key symptom of Covid-19 long-hauler syndrome. By JIM COLLINS Stocks quotes in this article: GME, JAGX In the midst of l’affaire GameStop (GME) , the most ridiculous reaction of the online brokers was Robinhood’s decision last week to publish a daily list of stocks that were either unavailable to trade, available […]
Read More

Jaguar Health’s EU subsidiary to go public in Italy via SPAC

By: Dulan Lokuwithana, SA News Editor Napo EU, a subsidiary being established by Jaguar Health (JAGX -15.6%) in Italy has chosen the AIM Italy to list, it was revealed in a webcast organized by the company and a sponsor of the SPAC. The sponsor of the proposed Post Pandemic Recovery special purpose acquisition company said that a group of multinational institutional investors […]
Read More

As More Deadly Strains Emerge, the Post Pandemic Recovery SPAC Gears up to Finance “Long-Hauler “treatment through proposed merger with Napo EU; Interview with Lisa Conte and Andreea Porcelli

Lisa Conte and Andreea Porcelli were interviewed again this week on Innovators with Jane King regarding long-hauler syndrome in post-COVID-19 recovery patients and Jaguar’s plans to explore the possibility of obtaining conditional marketing authorization in Europe to support development and commercialization of crofelemer for the COVID-related indication. When discussing post-acute COVID-19 long-hauler symptoms during a […]
Read More

Jaguar Health and Sponsor of Proposed Post Pandemic Recovery Equity SPAC to Host Webcast Wednesday, January 27th at 8:30 AM Eastern Time to Provide Updates Regarding the Potential Merger of Napo EU, the Company’s Anticipated Subsidiary in Italy

Andreea Porcelli, CEO of Swiss Growth Forum, will be a co-presenter on the webcast in her separate capacity as a sponsor of the proposed SPAC San Francisco, CA (January 21, 2021): Jaguar Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”) announced today that the Company and a sponsor of the proposed Post Pandemic Recovery Equity special […]
Read More

Subscribe to our newsletter

Sign up to receive latest news, updates, promotions, and special offers delivered directly to your inbox.
No, thanks